MalarVx
2012
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
$1.05M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Operator of a bio-pharmaceutical company. The company is focused on the development of in vitro culture systems for the malaria parasite which will lead to the development of an effective whole-parasite vaccine.
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- 307 Westlake Avenue North
- Suite 200
- Seattle, WA 98109
- United States
+1 (206) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore MalarVx’s full profile, request a free trial.
MalarVx Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 21-Jun-2017 | $1.05M | 00.00 | Completed | Startup | |
| 1. Angel (individual) | 23-Nov-2015 | 00000 | 00000 | Completed | Startup |
MalarVx Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Keiretsu Forum | Venture Capital | Minority | 000 0000 | 000000 0 |